About this trial
To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18-65 years, gender unrestricted
Confirmed third-degree burns, wound area 1%-5% TBSA
Admission within 72 hours after burn injury
Voluntarily signed informed consent
Disqualifiers
Pregnant or lactating females
Severe immunodeficiency or autoimmune disease
History of malignant tumor, or coagulation dysfunction
Severe cardiac, hepatic, or renal insufficiency
Trial design
Parallel
Treatments tested in this trial
HUMSCs combined with bovine type I collagen
Combination productTo evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds
bovine type I collagen
Biological/VaccineTo evaluate the safety and tolerability of bovine type I collagen in the treatment of third-degree burn wounds
Sterile blank dressing / Vaseline gauze
DeviceTo evaluate the safety and tolerability of sterile blank dressing / vaseline gauze in the treatment of third-degree burn wounds.
Treatment groups
Trial outcomes
Primary outcomes
Re-epithelialization areas
Re-epithelialization will be determined by clinical evaluations and recorded by digital color photographs
Complete burn wound healing
Time (days) to complete re-epithelialization of burned skin. It will be based on clinical evaluations and digital color photographs
Sponsors and contacts
Click on the lead sponsor to view all of their trials.